Author: Luis Felipe Ramos
Publisher:
ISBN:
Category :
Languages : pt-BR
Pages : 0
Book Description
English Abstract: This paper's objective is to verify in what measure patents granted to pharmaceutical industry, to protect medicines, are in attendance of intellectual property social function. It attempts to compare the benefits brought to society and to pharmaceutical industries by medicine patents, and to analyze the possibility of application of safeguard measures available in Brazilian law, in case of non-achievement of social function by the reported patents.
Concessão de Patentes à Indústria Farmacêutica
Author: Luis Felipe Ramos
Publisher:
ISBN:
Category :
Languages : pt-BR
Pages : 0
Book Description
English Abstract: This paper's objective is to verify in what measure patents granted to pharmaceutical industry, to protect medicines, are in attendance of intellectual property social function. It attempts to compare the benefits brought to society and to pharmaceutical industries by medicine patents, and to analyze the possibility of application of safeguard measures available in Brazilian law, in case of non-achievement of social function by the reported patents.
Publisher:
ISBN:
Category :
Languages : pt-BR
Pages : 0
Book Description
English Abstract: This paper's objective is to verify in what measure patents granted to pharmaceutical industry, to protect medicines, are in attendance of intellectual property social function. It attempts to compare the benefits brought to society and to pharmaceutical industries by medicine patents, and to analyze the possibility of application of safeguard measures available in Brazilian law, in case of non-achievement of social function by the reported patents.
TRIPS and Access to Medicines
Author: Renata Curzel
Publisher: Kluwer Law International B.V.
ISBN: 9403528745
Category : Law
Languages : en
Pages : 325
Book Description
Although ideally a patent system for pharmaceuticals should serve to incentivize research into the development of new medicines, the COVID-19 pandemic has exposed the equal importance of drug access and affordability. This book, by focusing on the Brazilian rule which makes the grant of pharmaceutical patents dependent on the prior consent of the National Health Surveillance Agency (ANVISA), shows how the Brazilian model affords an example for other countries to follow in dealing with tensions between patent protection and the right to healthcare. Based on an empirical study in which the author examined 147 reports issued by ANVISA as a basis for its decisions, the book deals with such central questions concerning the interface of regulation and innovation in the patent system as the following: compatibility between ANVISA’s prior consent mechanism and the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; how “evergreening” and “trivial patents” undermine public health and access to medicines; ways of correcting abuses of patent rights and controlling quality of patents; and the discourse on health as a human right. Along with her examination of ANVISA reports, the author analyzes how Article 229-C LPI, which introduced the need of ANVISA’s prior consent to the patent grant of pharmaceuticals in Brazil, has been interpreted in Brazilian case law. Interviews with Brazilian experts are also included. In its commitment to harmonizing patent rights and the right to access of affordable medicines, Brazil’s patent system for pharmaceuticals stands out as a workable response to the basic problem of access to medicines in the developing world. By describing the successes and failures in the Brazilian policy of promoting drug access, this book helps policymakers in developing and emerging countries to better explore TRIPS flexibilities when dealing with similar problems, and provides practitioners in the law of the World Trade Organization, patent law, competition law, and health law with a guide to how a more equitable pharmaceutical patenting system could work in practice.
Publisher: Kluwer Law International B.V.
ISBN: 9403528745
Category : Law
Languages : en
Pages : 325
Book Description
Although ideally a patent system for pharmaceuticals should serve to incentivize research into the development of new medicines, the COVID-19 pandemic has exposed the equal importance of drug access and affordability. This book, by focusing on the Brazilian rule which makes the grant of pharmaceutical patents dependent on the prior consent of the National Health Surveillance Agency (ANVISA), shows how the Brazilian model affords an example for other countries to follow in dealing with tensions between patent protection and the right to healthcare. Based on an empirical study in which the author examined 147 reports issued by ANVISA as a basis for its decisions, the book deals with such central questions concerning the interface of regulation and innovation in the patent system as the following: compatibility between ANVISA’s prior consent mechanism and the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; how “evergreening” and “trivial patents” undermine public health and access to medicines; ways of correcting abuses of patent rights and controlling quality of patents; and the discourse on health as a human right. Along with her examination of ANVISA reports, the author analyzes how Article 229-C LPI, which introduced the need of ANVISA’s prior consent to the patent grant of pharmaceuticals in Brazil, has been interpreted in Brazilian case law. Interviews with Brazilian experts are also included. In its commitment to harmonizing patent rights and the right to access of affordable medicines, Brazil’s patent system for pharmaceuticals stands out as a workable response to the basic problem of access to medicines in the developing world. By describing the successes and failures in the Brazilian policy of promoting drug access, this book helps policymakers in developing and emerging countries to better explore TRIPS flexibilities when dealing with similar problems, and provides practitioners in the law of the World Trade Organization, patent law, competition law, and health law with a guide to how a more equitable pharmaceutical patenting system could work in practice.
Proteção de patentes de produtos farmacêuticos
Author: Maria Stela Pompeu Brasil Frota
Publisher:
ISBN:
Category : Conflict of laws
Languages : pt
Pages : 214
Book Description
Publisher:
ISBN:
Category : Conflict of laws
Languages : pt
Pages : 214
Book Description
Balancing Wealth and Health
Author: Rochelle Dreyfuss
Publisher:
ISBN: 0199676747
Category : Law
Languages : en
Pages : 369
Book Description
"The research strategy, concepts, and methodologies developed in this book repay careful consideration not only for fruitful deployment to examine dynamics of health and intelectual property in other regions, but also for generating innovative insights in other fields of global regulatory governance"--Foreword.
Publisher:
ISBN: 0199676747
Category : Law
Languages : en
Pages : 369
Book Description
"The research strategy, concepts, and methodologies developed in this book repay careful consideration not only for fruitful deployment to examine dynamics of health and intelectual property in other regions, but also for generating innovative insights in other fields of global regulatory governance"--Foreword.
Intellectual Property Law and Access to Medicines
Author: Srividhya Ragavan
Publisher: Taylor & Francis
ISBN: 1000398730
Category : Law
Languages : en
Pages : 428
Book Description
The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of the trade regime to include intellectual property (IP) rights to the present, this book documents the role of different sets of actors – states, transnational business corporations, or civil society groups – and their influence on the structures – such as national and international agreements, organizations, and private entities – that have caused changes to healthcare and access to medication. Presenting the debates over patents, trade, and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), as it galvanized non-state and nonbusiness actors, the book highlights how an alternative framing and understanding of pharmaceutical patent rights emerged: as a public issue, instead of a trade or IP issue. The book thus offers an important analysis of the legal and political dynamics through which the contest for access to lifesaving medication has been, and will continue to be, fought. In addition to academics working in the areas of international law, development, and public health, this book will also be of interest to policy makers, state actors, and others with relevant concerns working in nongovernmental and international organizations.
Publisher: Taylor & Francis
ISBN: 1000398730
Category : Law
Languages : en
Pages : 428
Book Description
The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of the trade regime to include intellectual property (IP) rights to the present, this book documents the role of different sets of actors – states, transnational business corporations, or civil society groups – and their influence on the structures – such as national and international agreements, organizations, and private entities – that have caused changes to healthcare and access to medication. Presenting the debates over patents, trade, and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), as it galvanized non-state and nonbusiness actors, the book highlights how an alternative framing and understanding of pharmaceutical patent rights emerged: as a public issue, instead of a trade or IP issue. The book thus offers an important analysis of the legal and political dynamics through which the contest for access to lifesaving medication has been, and will continue to be, fought. In addition to academics working in the areas of international law, development, and public health, this book will also be of interest to policy makers, state actors, and others with relevant concerns working in nongovernmental and international organizations.
Science and Technology in Brazil
Author:
Publisher:
ISBN:
Category : Research
Languages : en
Pages : 396
Book Description
Publisher:
ISBN:
Category : Research
Languages : en
Pages : 396
Book Description
The New Political Economy of Pharmaceuticals
Author: Hans Löfgren
Publisher: Springer
ISBN: 1137315857
Category : Political Science
Languages : en
Pages : 247
Book Description
Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.
Publisher: Springer
ISBN: 1137315857
Category : Political Science
Languages : en
Pages : 247
Book Description
Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.
The Politics of the Pharmaceutical Industry and Access to Medicines
Author: Hans Löfgren
Publisher: Routledge
ISBN: 1351470590
Category : Social Science
Languages : en
Pages : 222
Book Description
The book studies the pharmaceutical industry of India. It is one of the most successful stories of economic expansion and improvements in public health. Indian firms have made access to quality medicines possible and affordable in many developing countries. Indian pharmaceuticals are also exported on a large scale to the United States and other highly regulated markets. A wave of mergers, acquisitions and tie-ups point to growing integration between Indian firms and global pharma multinationals. Please note: Taylor & Francis does not sell or distribute the Hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka
Publisher: Routledge
ISBN: 1351470590
Category : Social Science
Languages : en
Pages : 222
Book Description
The book studies the pharmaceutical industry of India. It is one of the most successful stories of economic expansion and improvements in public health. Indian firms have made access to quality medicines possible and affordable in many developing countries. Indian pharmaceuticals are also exported on a large scale to the United States and other highly regulated markets. A wave of mergers, acquisitions and tie-ups point to growing integration between Indian firms and global pharma multinationals. Please note: Taylor & Francis does not sell or distribute the Hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka
Pharmaceutical Innovation, Incremental Patenting and Compulsory Licensing
Author: Carlos M. Correa
Publisher:
ISBN:
Category :
Languages : en
Pages : 337
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 337
Book Description
Guia legal para o investidor estrangeiro no Brasil
Author:
Publisher:
ISBN:
Category : Business enterprises
Languages : pt
Pages : 568
Book Description
Publisher:
ISBN:
Category : Business enterprises
Languages : pt
Pages : 568
Book Description